Biography

Dr. Anand Srivastava has been associated with leading universities and research institutions of USA. In affiliation with University of California San Diego Medical College (UCSD), University of California Irvine Medical College (UCI), Salk Research Institute, San Diego, Burnham Institute For Medical Research, San Diego, University of California Los Angeles Medical College (UCLA), USA has helped develop several research programs and has an extensive research experience in the field of stem cell which is documented by several publications in revered scientific journals. Dr. Anand Srivastava’s success has its root in his unique background of expertise in Stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cell, tissue targeting, gene therapy and clinical research. There are many scientists who can work in a narrowly defined field but few have broad and multidisciplinary experience to carry out clinical research in a field as challenging as Stem cell biology, cancer and gene therapy field. Dr. Anand Srivastava’s wide-spectrum expertise is rare in clinical research and perfectly crafted to fit ideally with the GIOSTAR projects for stem cell transplant, cancer and gene therapy research. Dr. Srivastava is the Chairman and Cofounder of California based Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California, (U.S.A.). The company was formed with the vision to provide stem cell based therapy to aid those suffering from degenerative or genetic diseases around the world such as Parkinson's, Alzheimer's, Autism, Diabetes, Heart Disease, Stroke, Spinal Cord Injuries, Paralysis, Blood Related Diseases, Cancer and Burns. GIOSTAR is a leader in developing most advance stem cell based technology, supported by leading scientists with the pioneering publications in the area of stem cell biology. Company’s primary focus is to discover and develop a cure for human diseases with the state of the art unique stem cell based therapies and products. The Regenerative Medicine provides promise for treatments of diseases previously regarded as incurable. Giostar is world’s leading Stem cell therapy and research institute involved with stem cell therapy and research work for over last 18 years. It is headed by Dr Anand Srivastava, who is a world-renowned authority in the field of Stem cell biology, Cancer, Gene therapy. Several governments including USA, India, China, Turkey, Kuwait, Thailand and many others seek his advice and guidance on drafting their strategic and national policy formulations and program directions in the area of stem cell research, development and its regulations. Under his creative leadership a group of esteemed scientists and clinicians have developed and established Stem cell therapy for various types of Autoimmune diseases and blood disorders which are being offered to patients in USA and soon it will be offered on a regular clinical basis to the people around the globe. He is also the reviewer of more than thirty five top scientific journals in the world. GIOSTAR under the leadership of Dr. anand Srivastava is in charge of developing stem cell transplant program for four different State Governments in India with total population of approx. 155 million. GIOSTAR is pleased to announce that, in collaborations with Government of Gujarat, India, world's largest state of the art Stem Cell Treatment Hospital is taking shape in Surat Civil Hospital Campus. The four State Governments in India with help of GIOSTAR’s stem cell science are preparing to treat the large, poor populations in India suffering from sickle cell anemia and thalassemia. GIOSTAR is in negotiations with China’s public and private sector to start stem cell transplant program at ten different locations. GIOSTAR is involved in helping few world Governments to develop stem cell program policies in their respective countries. GIOSTAR launched in 2011, world’s first state-of-the-art private dedicated stem cell treatment hospital in India that was inaugurated by the Honorable Chief Minister Mr. Modi of State of Gujarat, India (now Prime Minister of India) and which received media coverage in prominent media outlets. Dr. Anand Srivastava’s research work has been presented in various national and international scientific meetings and conferences in USA, Japan, China, Korea, India, UAE, Germany and USA. His research articles have been published in peer reviewed medical scientific journals and his research work has been cited extensively by other scientists. Dr. Anand Srivastava’s expertise and scientific achievements were recognized by many scientific fellowships and by two consecutive award of highly prestigious and internationally recognized, JISTEC award from Science and Technology Agency, Government of Japan. Also, his research presentation was awarded with the excellent presentation award in the “Meeting of Clinical Chemistry and Medicine, Kyoto, Japan. He has also expertise in genetic engineering research, developmental biology, immunology, making the transgenic animals and his extraordinary expertise of searching and characterizing the new genes are ideal for our ongoing projects of developing the effective treatments for many degenerative diseases, genetic diseases and cancer. Based on his extraordinary scientific achievements his biography has been included in “WHO IS WHO IN AMERICA” data bank two times, first in 2005 and second in 2010. GIOSTAR Chairman, Dr. Anand Srivastava was involved in the group at UC Irvine which worked with the Christopher Reeve Foundation for the FIRST CLINICAL TRIAL APPROVED BY US FDA IN THE WORLD to use the ES cell to treat spinal cord injury in humans. One of Dr. Srivastava’s 2008 publications has recently been ranked at the top among a list of 20 most influential articles published in the field of stem cell and neuro-degenerative diseases in the world for five consecutive years. Stem Cell International devoted its special issue on stem cells to Dr. Srivastava in 2012. GIOSTAR Chairman Dr. Anand Srivastava has been invited to chair the session at 8th Annual World Congress of Regenerative Medicine & Stem Cell-Korea. He has been frequent guest on numerous international conferences as the keynote speaker, presenter, panel of experts etc. The speakers under his Chairmanship for this conference are the Who's Who in the field of Stem Cell Science from the top universities around the world such as Cambridge, Oxford, Imperial College London, University of California, Irvine, The International Society for Stem Cell Research (ISSCR) etc.


Subscribe